CompletedNot Applicable

Total Posterior-circulation Infarct Volume in Basilar Artery Stroke

France110 participantsStarted 2011-01-30

Plain-language summary

Preprocedural predictors of outcome in patients with acute basilar artery occlusion (ABAO) who underwent endovascular treatment (EVT) remain controversial. The Investigators aimed to analyse, in patients with ABAO treated by EVT, if pre-EVT DWI total posterior-circulation infarct volume (TPIV) was a predictor of 90-days outcomes

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * patient with a clinical diagnosis of acute stroke in the posterior-circulation within 24 hours from symptom onset; * patient with a pertinent clinical deficit following physician evaluation (no NIHSS limit); * acute basilar ischemia assessed on MRI matching clinical symptoms and including DWI; * ABAO confirmed by intra-arterial arteriography and treated using mechanical thrombectomy. Exclusion criteria: Patients were excluded if they were ineligible for an MRI or ineligible for MT for the following reasons: * prestroke modified Rankin Scale (mRS) score of \>2; * life expectancy \<3 months; * brainstem ischemia on DWI involving more than 80% of the area in axial view

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability

Timeframe: 90 day

Trial details

NCT IDNCT04650022

SponsorUniversity Hospital, Montpellier

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-10-01

View on ClinicalTrials.gov More Ischemic Stroke trials